MVD Inhibitors
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
6-Fluoromevalonate | 2822-77-7 | sc-280541 sc-280541A | 5 mg 25 mg | $235.00 $810.00 | ||
6-Fluoromevalonate serves as a pivotal intermediate in the mevalonate pathway, exhibiting unique reactivity due to the presence of a fluorine atom. This substitution alters the compound's electronic properties, enhancing its interaction with key enzymes involved in isoprenoid biosynthesis. The compound's structural conformation allows for specific binding affinities, influencing reaction rates and metabolic regulation. Its role in modulating enzyme activity highlights its significance in metabolic pathways. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $28.00 $88.00 $332.00 | 12 | |
Though it primarily inhibits HMG-CoA reductase, its downstream effect can influence MVD. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $30.00 $87.00 $132.00 $434.00 | 13 | |
Another HMG-CoA reductase inhibitor, affecting the overall mevalonate pathway. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $252.00 $495.00 | 9 | |
HMG-CoA reductase inhibitor; can influence the subsequent steps in the pathway. | ||||||
Pravastatin, Sodium Salt | 81131-70-6 | sc-203218 sc-203218A sc-203218B | 25 mg 100 mg 1 g | $68.00 $159.00 $772.00 | 2 | |
Another compound affecting HMG-CoA reductase, indirectly influencing MVD. | ||||||
Rosuvastatin | 287714-41-4 | sc-481834 | 10 mg | $142.00 | 8 | |
By inhibiting the earlier steps, it can potentially impact the function of MVD. | ||||||
Fluvastatin | 93957-54-1 | sc-279169 | 50 mg | $250.00 | ||
Another statin affecting the mevalonate pathway upstream of MVD. | ||||||
Alendronate acid | 66376-36-1 | sc-337520 | 5 g | $135.00 | 2 | |
While primarily affecting bone resorption, they also inhibit farnesyl diphosphate synthase, another enzyme in the mevalonate pathway, which can indirectly affect MVD. | ||||||
Zoledronic acid monohydrate | 165800-06-6 | sc-202859 sc-202859A sc-202859B | 25 mg 100 mg 1 g | $95.00 $289.00 $658.00 | 5 | |
Inhibits farnesyl diphosphate synthase in the mevalonate pathway. | ||||||
GGTI 298 | 1217457-86-7 | sc-361184 sc-361184A | 1 mg 5 mg | $189.00 $822.00 | 2 | |
Geranylgeranyl transferase inhibitor; by inhibiting a downstream target of the mevalonate pathway, it can indirectly influence the function of MVD. | ||||||